HER2+ breast cancer treatment and cardiotoxicity: monitoring and management von Jerusalem, Guy, Lancellotti, Patrizio, Kim, Sung-Bae

Volltext

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results fr... von Krop, Ian E, Dr, Kim, Sung-Bae, Prof, Martin, Antonio Gonzalez, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, MD, Badovinac-Crnjevic, Tanja, MD, Hoersch, Silke, MSc, Smitt, Melanie, MD, Wildiers, Hans, Prof

Volltext

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomi... von Kato, Ken, Cho, Byoung Chul, Takahashi, Masanobu, Okada, Morihito, Lin, Chen-Yuan, Chin, Keisho, Kadowaki, Shigenori, Ahn, Myung-Ju, Hamamoto, Yasuo, Doki, Yuichiro, Yen, Chueh-Chuan, Kubota, Yutaro, Kim, Sung-Bae, Hsu, Chih-Hung, Holtved, Eva, Xynos, Ioannis, Kodani, Mamoru, Kitagawa, Yuko

Volltext

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study von Sun, Jong-Mu, Shen, Lin, Shah, Manish A, Enzinger, Peter, Adenis, Antoine, Doi, Toshihiko, Kojima, Takashi, Metges, Jean-Philippe, Li, Zhigang, Kim, Sung-Bae, Cho, Byoung Chul, Mansoor, Wasat, Li, Shau-Hsuan, Sunpaweravong, Patrapim, Maqueda, Maria Alsina, Goekkurt, Eray, Hara, Hiroki, Antunes, Luis, Fountzilas, Christos, Tsuji, Akihito, Oliden, Victor Castro, Liu, Qi, Shah, Sukrut, Bhagia, Pooja, Kato, Ken

Volltext

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, rando... von Emens, Leisha A, Esteva, Francisco J, Beresford, Mark, Saura, Cristina, De Laurentiis, Michelino, Kim, Sung-Bae, Im, Seock-Ah, Wang, Yifan, Salgado, Roberto, Mani, Aruna, Shah, Jigna, Lambertini, Chiara, Liu, Haiying, de Haas, Sanne L, Patre, Monika, Loi, Sherene

Volltext

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase... von Hurvitz, Sara A, Hegg, Roberto, Chung, Wei-Pang, Im, Seock-Ah, Jacot, William, Ganju, Vinod, Chiu, Joanne Wing Yan, Xu, Binghe, Hamilton, Erika, Madhusudan, Srinivasan, Iwata, Hiroji, Altintas, Sevilay, Henning, Jan-Willem, Curigliano, Giuseppe, Perez-Garcia, José Manuel, Kim, Sung-Bae, Petry, Vanessa, Huang, Chiun-Sheng, Li, Wei, Frenel, Jean-Sebastien, Antolin, Silvia, Yeo, Winnie, Bianchini, Giampaolo, Loi, Sherene, Tsurutani, Junji, Egorov, Anton, Liu, Yali, Cathcart, Jillian, Ashfaque, Shahid, Cortés, Javier

Volltext

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer von Modi, Shanu, Jacot, William, Yamashita, Toshinari, Sohn, Joohyuk, Vidal, Maria, Tokunaga, Eriko, Tsurutani, Junji, Ueno, Naoto T., Prat, Aleix, Chae, Yee Soo, Lee, Keun Seok, Niikura, Naoki, Park, Yeon Hee, Xu, Binghe, Wang, Xiaojia, Gil-Gil, Miguel, Li, Wei, Pierga, Jean-Yves, Im, Seock-Ah, Moore, Halle C.F., Rugo, Hope S., Yerushalmi, Rinat, Zagouri, Flora, Gombos, Andrea, Kim, Sung-Bae, Liu, Qiang, Luo, Ting, Saura, Cristina, Schmid, Peter, Sun, Tao, Gambhire, Dhiraj, Yung, Lotus, Wang, Yibin, Singh, Jasmeet, Vitazka, Patrik, Meinhardt, Gerold, Harbeck, Nadia, Cameron, David A.

Volltext

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer von Kojima, Takashi, Shah, Manish A, Muro, Kei, Francois, Eric, Adenis, Antoine, Hsu, Chih-Hung, Doi, Toshihiko, Moriwaki, Toshikazu, Kim, Sung-Bae, Lee, Se-Hoon, Bennouna, Jaafar, Kato, Ken, Shen, Lin, Enzinger, Peter, Qin, Shu-Kui, Ferreira, Paula, Chen, Jia, Girotto, Gustavo, de la Fouchardiere, Christelle, Senellart, Helene, Al-Rajabi, Raed, Lordick, Florian, Wang, Ruixue, Suryawanshi, Shailaja, Bhagia, Pooja, Kang, S Peter, Metges, Jean-Philippe

Volltext

Bioluminescent Imaging Systems for Assay Developments von KIM, Sung-Bae, PAULMURUGAN, Ramasamy

Volltext

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer von Schlumberger, Martin, Tahara, Makoto, Wirth, Lori J, Robinson, Bruce, Brose, Marcia S, Elisei, Rossella, Habra, Mouhammed Amir, Newbold, Kate, Shah, Manisha H, Hoff, Ana O, Gianoukakis, Andrew G, Kiyota, Naomi, Taylor, Matthew H, Kim, Sung-Bae, Krzyzanowska, Monika K, Dutcus, Corina E, de las Heras, Begoña, Zhu, Junming, Sherman, Steven I

Volltext

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, pha... von André, Fabrice, Hee Park, Yeon, Kim, Sung-Bae, Takano, Toshimi, Im, Seock-Ah, Borges, Giuliano, Lima, Joao Paulo, Aksoy, Sercan, Gavila Gregori, Joaquin, De Laurentiis, Michelino, Bianchini, Giampaolo, Roylance, Rebecca, Miyoshi, Yasuo, Armstrong, Anne, Sinha, Rajni, Ruiz Borrego, Manuel, Lim, Elgene, Ettl, Johannes, Yerushalmi, Rinat, Zagouri, Flora, Duhoux, Francois P, Fehm, Tanja, Gambhire, Dhiraj, Cathcart, Jillian, Wu, Cai, Chu, Changan, Egorov, Anton, Krop, Ian

Volltext

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-c... von Soulières, Denis, Prof, Faivre, Sandrine, Prof, Mesía, Ricard, Prof, Remenár, Éva, Prof, Li, Shau-Hsuan, Prof, Karpenko, Andrey, Prof, Dechaphunkul, Arunee, MD, Ochsenreither, Sebastian, Prof, Kiss, Laura Anna, Prof, Lin, Jin-Ching, Prof, Nagarkar, Raj, Prof, Tamás, László, Prof, Kim, Sung-Bae, Prof, Erfán, Jozsef, Prof, Alyasova, Anna, Prof, Kasper, Stefan, Prof, Barone, Carlo, Prof, Turri, Sabine, MS, Chakravartty, Arunava, PhD, Chol, Marie, PhD, Aimone, Paola, Prof, Hirawat, Samit, Prof, Licitra, Lisa, Prof

Volltext

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breas... von Tolaney, Sara M, Wardley, Andrew M, Zambelli, Stefania, Hilton, John F, Troso-Sandoval, Tiffany A, Ricci, Francesco, Im, Seock-Ah, Kim, Sung-Bae, Johnston, Stephen RD, Chan, Arlene, Goel, Shom, Catron, Kristen, Chapman, Sonya C, Price, Gregory L, Yang, Zhengyu, Gainford, M Corona, André, Fabrice

Volltext

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study von Shen, Lin, Kato, Ken, Kim, Sung-Bae, Ajani, Jaffer A, Zhao, Kuaile, He, Zhiyong, Yu, Xinmin, Shu, Yongqian, Luo, Qi, Wang, Jufeng, Chen, Zhendong, Niu, Zuoxing, Zhang, Longzhen, Yi, Tienan, Sun, Jong-Mu, Chen, Jianhua, Yu, Guohua, Lin, Chen-Yuan, Hara, Hiroki, Bi, Qing, Satoh, Taroh, Pazo-Cid, Roberto, Arkenau, Hendrick-Tobias, Borg, Christophe, Lordick, Florian, Li, Liyun, Ding, Ningning, Tao, Aiyang, Shi, Jingwen, Van Cutsem, Eric

Volltext

Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma von Lim, Won Sub, Roh, Jong‐Lyel, Kim, Sung‐Bae, Choi, Seung‐Ho, Nam, Soon Yuhl, Kim, Sang Yoon

Volltext

Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐pos... von Kim, Sung‐Bae, Wildiers, Hans, Krop, Ian E., Smitt, Melanie, Yu, Ron, Lysbet de Haas, Sanne, Gonzalez‐Martin, Antonio

Volltext

Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy von Jeong, Jae Ho, Kim, Sung-Bae

Volltext

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial von Krop, Ian E, Dr, Kim, Sung-Bae, Prof, González-Martín, Antonio, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, Prof, Smitt, Melanie, MD, Yu, Ron, PhD, Leung, Abraham C F, MD, Wildiers, Hans, Prof

Volltext

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01) von Lee, Yun-Gyoo, Kang, Eun Joo, Keam, Bhumsuk, Choi, Jin-Hyuk, Kim, Jin-Soo, Park, Keon Uk, Lee, Kyoung Eun, Kwon, Jung Hye, Lee, Keun-Wook, Kim, Min Kyoung, Ahn, Hee Kyung, Shin, Seong Hoon, Kim, Hye Ryun, Kim, Sung-Bae, Yun, Hwan Jung

Volltext

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, p... von Swain, Sandra M, Dr, Kim, Sung-Bae, MD, Cortés, Javier, MD, Ro, Jungsil, MD, Semiglazov, Vladimir, MD, Campone, Mario, MD, Ciruelos, Eva, MD, Ferrero, Jean-Marc, MD, Schneeweiss, Andreas, MD, Knott, Adam, PhD, Clark, Emma, MSc, Ross, Graham, FFPM, Benyunes, Mark C, MD, Baselga, José, MD

Volltext